MedGemma vs Xiaomi MiMo-V2-Pro
MedGemma (2024) and Xiaomi MiMo-V2-Pro (2026) are general-purpose language models from Google DeepMind and Xiaomi. MedGemma ships a not-yet-sourced context window, while Xiaomi MiMo-V2-Pro ships a 1m-token context window. This comparison covers specs, pricing, API access, capabilities, benchmarks, input and output token costs, and production fit for coding and agent workloads. It focuses on practical selection signals rather than broad model-family marketing.
Xiaomi MiMo-V2-Pro is safer overall; choose MedGemma when vision-heavy evaluation matters.
Decision scorecard
Local evidence first| Signal | MedGemma | Xiaomi MiMo-V2-Pro |
|---|---|---|
| Best for | multimodal apps and tool-calling agents | tool-calling agents and long-context analysis |
| Decision fit | Agents, Vision, and JSON / Tool use | RAG, Agents, and Long context |
| Context window | — | 1m |
| Cheapest output | - | - |
| Provider routes | 1 tracked | 0 tracked |
| Shared benchmarks | 0 rows | 0 rows |
Decision tradeoffs
- MedGemma has broader tracked provider coverage for fallback and procurement flexibility.
- MedGemma uniquely exposes Vision, Multimodal, and Tool use in local model data.
- Local decision data tags MedGemma for Agents, Vision, and JSON / Tool use.
- Xiaomi MiMo-V2-Pro has the larger context window for long prompts, retrieval packs, or transcript analysis.
- Local decision data tags Xiaomi MiMo-V2-Pro for RAG, Agents, and Long context.
Monthly cost at traffic
Estimate token spend from the cheapest tracked input and output route or tier on this page.
MedGemma
Unavailable
No complete token price in local provider data
Xiaomi MiMo-V2-Pro
Unavailable
No complete token price in local provider data
Cost delta unavailable until both models have sourced input and output token prices.
Switch friction
- No overlapping tracked provider route is sourced for MedGemma and Xiaomi MiMo-V2-Pro; plan for SDK, billing, or endpoint changes.
- Check replacement coverage for Vision, Multimodal, and Tool use before moving production traffic.
- No overlapping tracked provider route is sourced for Xiaomi MiMo-V2-Pro and MedGemma; plan for SDK, billing, or endpoint changes.
- MedGemma adds Vision, Multimodal, and Tool use in local capability data.
Specs
| Specification | ||
|---|---|---|
| Released | 2024-07-01 | 2026-03-19 |
| Context window | — | 1m |
| Parameters | 4B | 1T |
| Architecture | decoder only | - |
| License | Proprietary | Proprietary |
| Openness | Proprietary | Proprietary |
| Commercial use | Commercial use with conditions | Commercial use with conditions |
| Knowledge cutoff | - | 2024-12 |
Pricing and availability
| Pricing attribute | MedGemma | Xiaomi MiMo-V2-Pro |
|---|---|---|
| Input price | - | - |
| Output price | - | - |
| Providers | - |
Pricing not yet sourced for either model.
Capabilities
| Capability | MedGemma | Xiaomi MiMo-V2-Pro |
|---|---|---|
| Vision | Yes | No |
| Multimodal | Yes | No |
| Reasoning | No | No |
| Function calling | Yes | Yes |
| Tool use | Yes | No |
| Structured outputs | Yes | No |
| Code execution | No | No |
| IDE integration | No | No |
| Computer use | No | No |
| Parallel agents | No | No |
Benchmarks
No shared benchmark rows are currently sourced for this pair.
Deep dive
The capability footprint differs most on vision: MedGemma, multimodal input: MedGemma, tool use: MedGemma, and structured outputs: MedGemma. Both models share function calling, so the practical split is not just feature count. Use those differences to decide whether the page is about raw model quality, agentic coding support, multimodal ingestion, or predictable structured API behavior.
Pricing coverage is uneven: MedGemma has no token price sourced yet and Xiaomi MiMo-V2-Pro has no token price sourced yet. Provider availability is 1 tracked routes versus 0. Treat unknown pricing as an integration gap, then verify the route you will actually call before estimating production spend.
Choose MedGemma when vision-heavy evaluation and broader provider choice are central to the workload. Choose Xiaomi MiMo-V2-Pro when provider fit are more important. For production, rerun your own prompts through the exact provider, region, and tool stack you plan to ship. This keeps the decision grounded in measurable tradeoffs instead of brand-level assumptions. It also helps separate model capability from provider packaging, which can change cost and latency. For teams standardizing a stack, that distinction is often the difference between a benchmark win and a reliable deployment.
FAQ
Is MedGemma or Xiaomi MiMo-V2-Pro open source?
MedGemma is listed under Proprietary. Xiaomi MiMo-V2-Pro is listed under Proprietary. License labels affect whether you can self-host, redistribute weights, or rely only on hosted APIs, so confirm the upstream license before deployment.
Which is better for vision, MedGemma or Xiaomi MiMo-V2-Pro?
MedGemma has the clearer documented vision signal in this comparison. If vision is mission-critical, validate it against the provider endpoint because model-level support and API-level exposure can differ. Use this as a quick comparison signal, then confirm the provider-specific limits before committing to production.
Which is better for multimodal input, MedGemma or Xiaomi MiMo-V2-Pro?
MedGemma has the clearer documented multimodal input signal in this comparison. If multimodal input is mission-critical, validate it against the provider endpoint because model-level support and API-level exposure can differ.
Which is better for function calling, MedGemma or Xiaomi MiMo-V2-Pro?
Both MedGemma and Xiaomi MiMo-V2-Pro expose function calling. The better choice depends on benchmark fit, context budget, pricing, and whether your provider route exposes the same capability surface. Use this as a quick comparison signal, then confirm the provider-specific limits before committing to production.
Which is better for tool use, MedGemma or Xiaomi MiMo-V2-Pro?
MedGemma has the clearer documented tool use signal in this comparison. If tool use is mission-critical, validate it against the provider endpoint because model-level support and API-level exposure can differ.
Where can I run MedGemma and Xiaomi MiMo-V2-Pro?
MedGemma is available on GCP Vertex AI. Xiaomi MiMo-V2-Pro is available on the tracked providers still being sourced. Provider coverage can affect latency, region availability, compliance posture, and fallback options.
Continue comparing
Last reviewed: 2026-05-22. Data sourced from public model cards and provider documentation.